Doris Apt

1.1k citations

20 papers · 866 indexed · h-index 11

Impact in

Epidemiology
- Cervical Cancer and HPV Research
Oncology

Papers in ⓘ

Virology 3
- HIV Research and Treatment 3
Genetics 6
- Virus-based gene therapy research 4

Co-authors: Hans‐Ulrich Bernard (5 shared papers)T Chong (2 shared papers)Yichun Liu (2 shared papers)Guntram Suske (1 shared paper)Muhammad Isa (1 shared paper)Bernd Gloss (1 shared paper)Yi Liu (1 shared paper)Juha Punnonen (4 shared papers)
Journals: Expert Opinion on Biological Therapy (3 papers)Virology (2 papers)Journal of Virology (2 papers)Human Gene Therapy (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Singapore Germany

In The Last Decade

Doris Apt

20 papers receiving 851 citations

Peers

Countries citing papers authored by Doris Apt

Since Specialization

Citations

This map shows the geographic impact of Doris Apt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Apt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Apt more than expected).

Fields of papers citing papers by Doris Apt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Apt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Apt. The network helps show where Doris Apt may publish in the future.

Co-authors

The 25 scholars most cited alongside Doris Apt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doris Apt Line = papers co-authored together Doris Apt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High Sp1/Sp3 Ratios in Epithelial Cells during Epithelial Differentiation and Cellular Transformation Correlate with the Activation of the HPV-16 Promoter Virology ·Doris Apt, Robin M. Watts, Guntram Suske, Hans‐Ulrich Bernard	1996	140
2	The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription Journal of Virology ·T Chong, Doris Apt, Bernd Gloss, Muhammad Isa, Hans‐Ulrich Bernard	1991	130
3	Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors Clinical Cancer Research ·Saoirse Dolly, Andrew J. Wagner, Johanna C. Bendell, Hedy L. Kindler, Lee M. Krug, Tanguy Y. Seiwert, Marjorie G. Zauderer, Martijn P. Lolkema, Doris Apt, Ru-Fang Yeh, Jill Fredrickson, Jill M. Spoerke, Hartmut Koeppen, Joseph A. Ware, Jennifer Lauchle, Howard A. Burris, Johann S. de Bono	2016	105
4	Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study Annals of Oncology ·Peter Vuylsteke, Manon Huizing, Katarína Petráková, Rebecca Roylance, Robert Laing, Stephen Chan, F. Abell, Steven Gendreau, Isabelle Rooney, Doris Apt, Jing Zhou, Stina Mui Singel, Louis Fehrenbacher	2016	91
5	Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16 Journal of Virology ·Doris Apt, T Chong, Yi Liu, Hans‐Ulrich Bernard	1993	86
6	Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen Vaccine ·Doris Apt, Kanakatte Raviprakash, Alice Brinkman, Andrey Semyonov, Shumin Yang, Craig Skinner, Lori Diehl, Richard C. Lyons, Kevin R. Porter, Juha Punnonen	2005	74
7	Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner Nucleic Acids Research ·Doris Apt, Yichun Liu, Hans‐Ulrich Bernard	1994	70
8	A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques Virology ·Kanakatte Raviprakash, Doris Apt, Alice Brinkman, Craig Skinner, Shumin Yang, Glenn Dawes, Dan Ewing, Shuenn-Jue Wu, S Bass, Juha Punnonen, Kevin R. Porter	2006	54
9	NFI-B3, a Novel Transcriptional Repressor of the Nuclear Factor I Family, Is Generated by Alternative RNA Processing Journal of Biological Chemistry ·Yichun Liu, Hans‐Ulrich Bernard, Doris Apt	1997	49
10	Diverse Plasmid DNA Vectors by Directed Molecular Evolution of Cytomegalovirus Promoters Human Gene Therapy ·Anne Wright, Andrey Semyonov, Glenn Dawes, Andreas Crameri, Rick Lyons, Willem P.C. Stemmer, Doris Apt, Juha Punnonen	2005	20
11	Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony‐stimulating factor derivative Maxy‐G34 and pegfilgrastim in rats Cell Proliferation ·Markus Scholz, Christoph Engel, Doris Apt, Sudharsan Sankar, E. J. C. Goldstein, Markus Loeffler	2009	14
12	EpCAM-specific Vaccine Response by Modified Antigen and Chimeric Costimulatory Molecule in Cynomolgus Monkeys Journal of Immunotherapy ·Margaret Neighbors, Doris Apt, Jean C-C. Chang, Alice Brinkman, Isabelle Sipos-Solman, Randal Ong, Steven R. Leong, Juha Punnonen	2008	7
13	Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies Expert Opinion on Biological Therapy ·Christopher P. Locher, Volker Heinrichs, Doris Apt, Robert G. Whalen	2004	7
14	High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells. PubMed ·Peter Altevogt, Doris Apt	1988	5
15	Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement. PubMed ·Doris Apt, Jeanette Schreck, Peter Altevogt	1989	4
16	An open-label, dose-escalating study of Maxy-G34, a novel potent, long-acting Pegylated G-CSF, compared with pegfilgrastim (PF) for the treatment of chemotherapy induced neutropenia (CIN) Journal of Clinical Oncology ·L. Schwartzberg, Sudharsan Sankar, Doris Apt, E. J. C. Goldstein, Santosh Vetticaden, Kerim Chitour, David Gilfoyle, S. Kim, Ulrich Keilholz, K. Possinger	2009	3
17	Abstract P5-19-10: Tolerability and anti-tumor activity of the oral PI3K inhibitor GDC-0941 in combination with paclitaxel, with and without bevacizumab or trastuzumab in patients with locally recurrent or metastatic breast cancer Cancer Research ·Patrick Schöffski, Sara Cresta, Ingrid A. Mayer, Hans Wildiers, Isabelle Rooney, Doris Apt, Steve Gendreau, Kari M. Morrissey, Mark R. Lackner, Jill M. Spoerke, Eric P. Winer	2015	3
18	1803 PEGGY: A phase II randomised study of the PI3-kinase (PI3K) inhibitor pictilisib (GDC-0941) plus paclitaxel in patients (pts) with hormone receptor (HR)-positive, HER2-negative locally recurrent or metastatic breast cancer (mBC) European Journal of Cancer ·Peter Vuylsteke, M. Huizing, Katarína Petráková, Rebecca Roylance, Robert Laing, Stephen L. Chan, F. Abell, Doris Apt, Jiabao Zhou, Stina Mui Singel, Louis Fehrenbacher	2015	2
19	Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies Expert Opinion on Biological Therapy ·Christopher P. Locher, Volker Heinrichs, Doris Apt, Robert G. Whalen	2004	1
20	Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies Expert Opinion on Biological Therapy ·Christopher P. Locher, Volker Heinrichs, Doris Apt, Robert G. Whalen	2004	1

About Doris Apt

Doris Apt is a scholar working on Virology, Genetics, Endocrinology, Oncology and Epidemiology, having authored 20 papers that have together received 866 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Virus-based gene therapy research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), HIV Research and Treatment (3 papers), Cervical Cancer and HPV Research (3 papers), Advanced Breast Cancer Therapies (3 papers), RNA Research and Splicing (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Epidemiology (249 citations), Oncology (189 citations), Virology (32 citations), Molecular Biology (450 citations) and Genetics (64 citations). Doris Apt has collaborated with scholars based in United States, Singapore and Germany. Frequent co-authors include Hans‐Ulrich Bernard, T Chong, Yichun Liu, Guntram Suske, Muhammad Isa, Bernd Gloss, Yi Liu, Juha Punnonen, Shumin Yang and Kevin R. Porter. Their work appears in journals such as Expert Opinion on Biological Therapy, Virology, Journal of Virology, Human Gene Therapy and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact